Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Body Weight » Overweight » Obesity
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Nutrition Disorders » Overnutrition » Overweight » Obesity
Description
A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). MeSH
Hierarchy View
Subtype Terms (7)
Obesity, Abdominal
78 drugs (29 approved, 49 experimental)
Obesity Hypoventilation Syndrome
2 drugs (1 approved, 1 experimental)
Obesity, Maternal
1 approved drug
Obesity, Metabolically Benign
4 drugs (2 approved, 2 experimental)
Obesity, Morbid
95 drugs (78 approved, 17 experimental)
Pediatric Obesity
66 drugs (31 approved, 35 experimental)
Prader-Willi Syndrome
32 drugs (15 approved, 17 experimental)
Approved Indicated Drugs (36)
Phase 3 Indicated Drugs (47)
Phase 2 Indicated Drugs (137)
Phase 1 Indicated Drugs (105)
Other Experimental Indicated Drugs (330)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23)
casein glycomacropeptide (cgmp)
chenodeoxycholic acid (Chenix)
l-cysteine (cysteine hydrochloride)
live pediococcus pentosaceus lp28
Organization Involved with Phase 4 Indications (103)
Aristotle University of Thessaloniki
Daewoong Pharmaceutical Co. LTD.
European Foundation for the Study of Diabetes
Federal University of Health Science of Porto Alegre
Federal University of Pernambuco
Federal University of Rio Grande do Sul
Funch-Jensen, Peter, M.D., D.M.Sc.
Fundação de Amparo à Pesquisa do Estado de São Paulo
Fundación Cardiovascular de Colombia
Long Beach Memorial Medical Center
Louisiana Office of Group Benefits
Maryland Laser Skin and Vein Institute
National Center for Research Resources (NCRR)
National Health Service, United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
People's Liberation Army of China
Pontificia Universidad Catolica de Chile
St. Antonius Hospital, Nieuwegein
The University of Texas, Dallas
Universidad Autonoma de San Luis Potosi
Universidad Complutense de Madrid
University of British Columbia
University of California, Irvine
Organization Involved with Phase 3 Indications (72)
Center for Health, Exercise and Sport Sciences, Serbia
Children's National Medical Center
Elizabeth Glaser Pediatric AIDS Foundation
Hospital General de México Dr. Eduardo Liceaga
Jiangsu Kanion Pharmaceutical Co., Ltd
Korea Health Industry Development Institute
Laboratorios Silanes S.A. de C.V.
Lithuanian University of Health Sciences
National Coordinator Center of Clinical Trials (CENCEC)
National Institute on Aging (NIA)
National Medical Centre Siglo XXI Mexican Institute for Social Security
Office of Dietary Supplements (ODS)
Postgraduate Institute of Medical Education and Research
State University of New York, Buffalo
UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France
Organization Involved with Phase 2 Indications (95)
Albany College of Pharmacy and Health Sciences
Canadian Institutes of Health Research (CIHR)
Case Western Reserve University
ConjuChem Biotechnologies Inc.
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Federal University of Minas Gerais
Icahn School of Medicine at Mount Sinai
Innovent Biologics (Suzhou) Co. Ltd.
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Institut Hospital del Mar d'Investigacions Mèdiques
Internal Medicine Associates of Charlotte
Medical University of South Carolina
Mid-Atlantic Epilepsy and Sleep Center
National Autonomous University of Mexico
National Institute of Child Health and Human Development (NICHD)
OAXACA SITE MANAGEMENT ORGANIZATION, SC
Royal Veterinary & Agricultural University, Denmark
Shahid Sadoughi University of Medical Science
Shifa Ul Mulk Memorial Hospital
Spaulding Clinical Research Inc.
St. Luke's-Roosevelt Hospital Center
Organization Involved with Phase 1 Indications (25)
Organization Involved with Other Experimental Indications (127)
Agriculture and Agri-Food Canada
American Society of Bariatric Physicians
Bambino Gesù Hospital and Research Institute
Biotechnology and Biological Sciences Research Council
Bogomolets National Medical University
California Table Grape Commission
Catholic University of Sacred Heart, Rome
Center for Weight Management, California
Centre Hospitalier Universitaire de la Réunion
Centro de Estudios Cardiometabólicos S.C. (CESCAM)
Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad Irapuato
China Academy of Chinese Medical Sciences
Clinica Universidad de Navarra
Diabetological centre, Dreieich, Germany
Eskisehir Osmangazi University
Federal University of Rio de Janeiro
Huazhong University of Science and Technology
Instituto Mexicano del Seguro Social
Instituto Nacional de Cardiologia Ignacio Chavez
Inulina y Miel de Agave S.A. de C.V. (IMAG)
Katholieke Universiteit Leuven
Lovisenberg Diakonale Hospital
Morinaga Milk Industry Co. Ltd., Japan
National Institute of General Medical Sciences (NIGMS)
National Polytechnic Institute, Mexico
National University of Ireland
National University of Singapore
Northern Norway Regional Health Authority
Pennington Biomedical Research Center
Regina Qu'Appelle Health Region
Reykjalundur Rehabilitation Center
Rio de Janeiro State University
Shahid Beheshti University of Medical Sciences
State University of New York, Syracuse
Swiss Federal Institute of Technology
Taras Shevchenko National University of Kyiv
The California Table grape Commission
Top Institute Food and Nutrition
TsaoTun Psychiatric Center, Department of Health, Taiwan
Université catholique de Louvain
University Hospital of North Norway
University of Alabama, Birmingham
University of California, Davis
University of California, Los Angeles
University of Monterrey, Mexico
University of North Carolina at Chapel Hill
University of Southern Denmark
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
